Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Alterity Therapeutics ( (AU:ATH) ).
Alterity Therapeutics Limited announced the cessation of 35 million securities due to the expiry of options without exercise or conversion as of September 17, 2025. This cessation may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategy and future growth prospects.
More about Alterity Therapeutics
Alterity Therapeutics Limited operates in the biotechnology industry, focusing on developing therapeutic products for neurodegenerative diseases.
YTD Price Performance: 20.0%
Average Trading Volume: 13,820,661
Technical Sentiment Signal: Sell
Current Market Cap: A$130.5M
See more data about ATH stock on TipRanks’ Stock Analysis page.